FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know

Published Jul 28, 2021

FDA Approves Combination of Keytruda & Lenvima For Treatment Of Advanced Uterine Cancer: What Women Need To Know

The Food and Drug Administration (FDA) has just approved a new treatment option for women with advanced uterine cancer. The combination of immunotherapy drugs Keytruda and Lenvima for the disease after initial treatment has failed. Here's what to know.

NOW
PLAYING
A Cancer Survivor Shares How She Came to the Correct Diagnosis after a Doctor Ignored Her Concerns
NOW
PLAYING
What Are the Various Treatment Options for Multiple Myeloma Induction Therapy?
NOW
PLAYING
Multiple Myeloma Relapse: Is There a Go-To Treatment?
NOW
PLAYING
What is the Maintenance Phase of Multiple Myeloma and How Do You Decide Which Drug to Be On?
NOW
PLAYING
First Lady and Breast Cancer Fighter Casey DeSantis Pushes for Change
NOW
PLAYING
Remembering 'Young Frankenstein' Star Madeline Kahn Who Died from Ovarian Cancer at Age 57

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.